Jiangsu (SH:688426) Xin Lang Cai Jing·2025-11-17 05:46Group 1 - The core viewpoint of the news is that Jiangsu Kangwei Century Biotechnology Co., Ltd. has seen a stock price increase of 5.13%, reaching 32.80 yuan per share, with a total market capitalization of 3.69 billion yuan [1] - The company was established on September 3, 2010, and went public on October 25, 2022, focusing on the research, production, and sales of molecular detection products, as well as providing molecular detection services [1] - The main revenue composition of the company includes 89.14% from product sales, 10.86% from services, and 0.00% from other sources [1] Group 2 - From the perspective of fund holdings, one fund under Dongzheng Asset Management has a significant position in Kangwei Century, with the "Oriental Red Quantitative Selection Mixed Fund A" holding 29,500 shares, accounting for 2.47% of the fund's net value [2] - The fund has achieved a year-to-date return of 15.23%, ranking 5160 out of 8213 in its category, and a one-year return of 14.44%, ranking 4843 out of 8130 [2] - The fund manager, Xu Xijia, has been in position for 6 years and 112 days, with the fund's total asset size at 7.02 billion yuan and a best return of 53.13% during the tenure [2]